Deloitte Access Economics Report: Cost effectiveness of pain devices
The Neuromodulation Society of Australia and New Zealand (NSANZ), engaged Deloitte Access Economics to estimate the cost effectiveness of neuromodulation treatment through spinal cord stimulation (SCS) and intrathecal pumps, which are collectively referred to as pain devices.
Private Health Insurance Policies
Potential differences in Private Health Insurance policy coverage for Pain Management with/without device and other selected categories
